Clark Center Forum

About the Clark Center Forum

The Forum for the Kent A. Clark Center for Global Markets is home to the European, Finance, and US Economic Experts Panels as well as a repository of thoughtful, current, and reliable information regarding topics of the day.
Articles

New Visa Ban

An executive order by President Trump in late June has suspended a range of visas for skilled workers. We invited our panel to express their views on the potential impact of the visa ban on US leadership in science and innovation; on the attractiveness of US universities for foreign students; and on the location of […] 
US

New Visa Ban

Question A:

Even if it is temporary, the ban on visas for skilled workers, including researchers, will weaken US leadership in STEM and R&D.

Question B:

Significantly fewer top foreign students will be attracted to US universities as a result of increased restrictions on visas for skilled workers.

Question C:

If increased restrictions on visas for skilled workers are made permanent, a noticeable share of research activities by US and foreign companies will move abroad.

 
COVID-19

Identification and Estimation of Undetected COVID-19 Cases Using Testing Data from Iceland

James J. Stock et al In the early stages of the pandemic, testing targeted individuals whose symptoms and/or jobs placed them at a high presumed risk of infection. This potentially results in a high proportion of cases going undetected. In an update of our April paper, we use public data from two Icelandic testing regimes […] 
Europe

The Search for a Vaccine

This week’s IGM European Economic Experts Panel statements:

 

A) Given the social and regulatory pressures to keep prices down for drugs and vaccines to treat Covid-19, the financial incentives for pharmaceutical companies to invest in such products are below the value of the investment to society.

B) Government commitments to pay developers and manufacturers above average costs for an effective vaccine or drug treatments for Covid-19 would accelerate production.

C) Given the positive externalities from vaccination, an effective Covid-19 vaccine should have priority in public healthcare funding even in countries where other diseases cause more death and disability.

  
US

The Search for a Vaccine

This week’s IGM Economic Experts Panel statements:

A) Given the social and regulatory pressures to keep prices down for drugs and vaccines to treat Covid-19, the financial incentives for pharmaceutical companies to invest in such products are below the value of the investment to society.

B) Government commitments to pay developers and manufacturers above average costs for an effective vaccine or drug treatments for Covid-19 would accelerate production.

C) Given the positive externalities from vaccination, an effective Covid-19 vaccine should be mandatory for every US resident (except those with health exceptions, such as infants and people with compromised immunity) with the cost covered by the federal government. 
Economic Outlook Survey

Round 03 – FiveThirtyEight/IGM COVID-19 Economic Outlook

This is the third round of the FiveThirtyEight/IGM COVID-19 Economic Outlook survey. This survey series is overseen by Professors Allan Timmermann and Jonathan Wright. The list of experts answering the questions is identified in the post along with the responses. Individual responses are anonymous. A simple summary of responses of Round 03 appears here on […] 
COVID-19

Will COVID-19 be Followed by Inflation? An Inter-Generational Transfer Perspective

Lubos Pastor Governments around the world are spending mightily to deal with the fallout of the COVID-19 crisis. When the dust settles, the burden of public debt will be much heavier than it is today. Some countries’ debt-to-GDP ratios are likely to grow by more than 20%. How will policymakers deal with this mountain of […]